Analysis of influence of background therapy for comorbidities in the period before infection on the risk of the lethal COVID outcome. Data from the international ACTIV SARS-CoV-2 registry («Analysis of chronic non-infectious diseases dynamics after COVID-19 infection in adult patients SARS-CoV-2»)
https://doi.org/10.18087/cardio.2021.9.n1680
Abstract
Aim To study the effect of regular drug therapy for cardiovascular and other diseases preceding the COVID-19 infection on severity and outcome of COVID-19 based on data of the ACTIVE (Analysis of dynamics of Comorbidities in paTIents who surVived SARS-CoV-2 infEction) registry.
Material and methods The ACTIVE registry was created at the initiative of the Eurasian Association of Therapists. The registry includes 5 808 male and female patients diagnosed with COVID-19 treated in a hospital or at home with a due protection of patients’ privacy (data of nasal and throat smears; antibody titer; typical CT imaging features). The register territory included 7 countries: the Russian Federation, the Republic of Armenia, the Republic of Belarus, the Republic of Kazakhstan, the Kyrgyz Republic, the Republic of Moldova, and the Republic of Uzbekistan. The registry design: a closed, multicenter registry with two nonoverlapping arms (outpatient arm and in-patient arm). The registry scheduled 6 visits, 3 in-person visits during the acute period and 3 virtual visits (telephone calls) at 3, 6, and 12 mos. Patient enrollment started on June 29, 2020 and was completed on October 29, 2020. The registry completion is scheduled for October 29, 2022. The registry ID: ClinicalTrials.gov: NCT04492384. In this fragment of the study of registry data, the work group analyzed the effect of therapy for comorbidities at baseline on severity and outcomes of the novel coronavirus infection. The study population included only the patients who took their medicines on a regular basis while the comparison population consisted of noncompliant patients (irregular drug intake or not taking drugs at all despite indications for the treatment).
Results The analysis of the ACTIVE registry database included 5808 patients. The vast majority of patients with COVID-19 had comorbidities with prevalence of cardiovascular diseases. Medicines used for the treatment of COVID-19 comorbidities influenced the course of the infectious disease in different ways. A lower risk of fatal outcome was associated with the statin treatment in patients with ischemic heart disease (IHD); with angiotensin-converting enzyme inhibitors (ACEI)/angiotensin receptor antagonists and with beta-blockers in patients with IHD, arterial hypertension, chronic heart failure (CHF), and atrial fibrillation; with oral anticoagulants (OAC), primarily direct OAC, clopidogrel/prasugrel/ticagrelor in patients with IHD; with oral antihyperglycemic therapy in patients with type 2 diabetes mellitus (DM); and with long-acting insulins in patients with type 1 DM. A higher risk of fatal outcome was associated with the spironolactone treatment in patients with CHF and with inhaled corticosteroids (iCS) in patients with chronic obstructive pulmonary disease (COPD).
Conclusion In the epoch of COVID-19 pandemic, a lower risk of severe course of the coronavirus infection was observed for patients with chronic noninfectious comorbidities highly compliant with the base treatment of the comorbidity.
About the Authors
E. I. TarlovskayaRussian Federation
MD, PhD, Professor, Chairperson of the Eurasian Association of Therapists branch in Nizhny Novgorod, head of the Department of therapy and cardiology
A. G. Arutyunov
Russian Federation
MD, PhD, Professor, Secretary General of the Eurasian Association of Therapists
A. O. Konradi
Russian Federation
Сorresponding member of the Russian Academy of Sciences. MD, PhD, Professor, Deputy General Director of scientific work
Yu. M. Lopatin
Russian Federation
MD, PhD, Professor, Head of the Departrment of Cardiology and Functional Diagnostics, Faculty of Advanced Training for Doctors
A. P. Rebrov
Russian Federation
PhD, MD, Professor at the Department of the Internal Medicine
S. N. Tereshchenko
Russian Federation
MD, Professor, head of the Department of myocardial diseases and heart failure
A. I. Chesnikova
Russian Federation
MD, PhD, Professor, Professor in the Department of Internal Medicine No.1
H. G. Hayrapetyan
Armenia
MD, PhD, Doctor of Science, Prof., Head of Cardiology Center, Head of Cardiology Department
A. P. Babin
Moldova, Republic of
MD, PhD, Associate Professor at the Department of Family Medicine
I. G. Bakulin
Russian Federation
MD, PhD, professor, Dean of the General Medicine Faculty, Head of the department of Propedeutics of Internal Diseases, Gastroenterology and Dietology named after S.M. Ryss, Internal Medicine Adviser to the Ministry of Health (the Northwestern federal district of Russia)
N. V. Bakulina
Russian Federation
MD, PhD, Professor, Head of the department of Internal Diseases, Clinical Pharmacology and Nephrology
L. A. Balykova
Russian Federation
MD, PhD, professor, Director of the Medicine Institute, corresponding member of the Russian Academy of Sciences
A. S. Blagonravova
Russian Federation
Vice rector for research, professor of epidemiology, microbiology and evidence based medicine, M.D.
M. V. Boldina
Russian Federation
associate Professor of the Department of therapy and cardiology, PhD in Medicine
A. R. Vaisberg
Russian Federation
Department of Therapy and Cardiology, Associate Professor
A. S. Galyavich
Russian Federation
Chief Cardiologist of the Republic of Tatarstan, Corresponding Member of the Academy of Sciences of the Republic of Tatarstan Head of the Republican Center for Cardiovascular Diseases, Head of the Department of Faculty Therapy
V. V. Gomonova
Russian Federation
Deputy Chief Physician
N. Yu. Grigorieva
Russian Federation
MD, PhD, associate Professor, head of the Department of clinical medicine
I. V. Gubareva
Russian Federation
MD, PhD, Dr. Med. Sci, head of Internal Diseases Department, Associated Professor
I. V. Demko
Russian Federation
MD, PhD, professor, Head of the Department of Hospital Therapy and Immunology with Postgraduate Education
A. V. Evzerikhina
Russian Federation
сandidate of medical sciences, deputy chief physician
A. V. Zharkov
Russian Federation
chief physician
U. K. Kamilova
Uzbekistan
MD, PhD, Professor, Deputy Director of Scientific Work
Z. F. Kim
Russian Federation
PhD, associate professor, deputy chief physician
T. Yu. Kuznetsova
Russian Federation
MD, PhD, associated professor, head of the department of Faculty Therapy, Phthisiology, Infectious Diseases and Epidemiology
N. V. Lareva
Russian Federation
MD, PhD, professor, head of the department of Therapy at the Faculty of Advanced Training and Professional Continuing Education
E. V. Makarova
Russian Federation
MD, DSc, head of the Department of Propaedeutics of internal diseases
S. V. Malchikova
Russian Federation
MD, PhD, associate professor of the Department of Clinical Therapy
S. V. Nedogoda
Russian Federation
MD, PhD, professor, vice-rector for clinical work and regional health development, head of the Department of Internal Medicine
M. M. Petrova
Russian Federation
MD, PhD, professor, head of the Department of Polyclinic Therapy and Family Medicine with a Course of Postgraduate Education
I. G. Pochinka
Russian Federation
MD, PhD, associate professor at the Department of Enocrinology and Internal Medicine, head of the Department of Cardiology №1
K. V. Protasov
Russian Federation
MD, PhD, professor, deputy director of research
D. N. Protsenko
Russian Federation
PhD, Dr. med, chief physician, head of the anesthesiology and resuscitation department of the school of continuing medical education
D. Yu. Ruzanau
Belarus
MD, associate professor, vice-rector for clinical work, professor at the Department of Phthisiology and Pulmonology
S. A. Sayganov
Russian Federation
MD, PhD, rector, head of the Department of Hospital Therapy and Cardiology
A. S. Sarybaev
Kyrgyzstan
MD, PhD, Head of the National Center of Cardiology and Internal Medicine named after prof. M. Mirrakhimov
N. M. Selezneva
Russian Federation
MD, associate professor at the Department of Hospital Therapy
A. B. Sugraliev
Kazakhstan
PhD, head of the Department of Internal Diseases with a Course of Propaedeutics
I. V. Fomin
Russian Federation
MD, PhD, associate professor, head of the department of hospital therapy
O. V. Khlynova
Russian Federation
MD, PhD, Professor, corresponding member of the Russian Academy of Sciences, Head of the Department of Hospital Therapy
O. Yu. Chizhova
Russian Federation
MD, PhD, professor at the department of Propedeutics of Internal Diseases, Gastroenterology and Dietology named after S.M. Ryss
I. I. Shaposhnik
Russian Federation
MD, PhD, professor, head of the department of the propaedeutics of internal diseases
D. A. Shсukarev
Russian Federation
head of department of infectious deseases
A. K. Abdrahmanova
Kazakhstan
MD, MD, head of the Department of Infectious Diseases, chief physician
S. A. Avetisian
Armenia
clinical resident at cardiology department
H. G. Avoyan
Armenia
cardiologist
K. K. Azarian
Armenia
cardiologist
G. T. Aimakhanova
Kazakhstan
cardiologist
D. A. Ayipova
Kyrgyzstan
head of the department of nephrology
A. Ch. Akunov
Kyrgyzstan
PhD, head of the Department of urgent cardiology and reanmation-2
M. K. Alieva
Russian Federation
therapist
A. V. Aparkina
Russian Federation
MD, assistant at the Department of Hospital Therapy, Medical Faculty
O. R. Aruslanova
Russian Federation
MD, cardiovascular surgeon
E. Yu. Ashina
Russian Federation
assistant at the Department of Propedeutics of Internal Diseases
O. Yu. Badina
Russian Federation
Head of the Infectious Diseases Department
O. Yu. Barisheva
Russian Federation
MD, PhD, associated professor, professor of department of hospital therapy
A. S. Batchayeva
Russian Federation
clinical laboratory diagnostician
A. M. Bitieva
Russian Federation
cardiologist
I. U. Bikhteyev
Russian Federation
student
N. A. Borodulina
Russian Federation
cardiologist
M. V. Bragin
Russian Federation
student
A. M. Budu
Moldova, Republic of
head at the Department of Therapy
L. A. Burygina
Russian Federation
PhD, chief doctor
G. A. Bykova
Russian Federation
MD, associate professor at the Department of Hospital Care, pulmonologist
K. R. Vagapova
Russian Federation
endocrinologist
D. D. Varlamova
Russian Federation
student
N. N. Vezikova
Russian Federation
MD, PhD, Professor, head of department of hospital therapy
E. A. Verbitskaya
Russian Federation
resident of Department of Нospital Therapy and Immunology with Postgraduate Education Course
O. E. Vilkova
Russian Federation
Dr. Med., senior lecturer at the Department of Clinical Medicine
E. A. Vinnikova
Russian Federation
attending physician
V. V. Vustina
Russian Federation
MD, cardiologist
E. A. Gаlova
Russian Federation
candidate of medical sciences, deputy director for science of the University clinic
V. V. Genkel
Russian Federation
MD, PhD in medicine, associated professor at the Department of Propedeutics of Internal Medicine
E. I. Gorshenina
Russian Federation
MD, associate professor at the Department of Hospital Care
R. V. Gostishev
Russian Federation
PhD, Dr. Med., deputy chief physician for Prospective Development
E. V. Grigorieva
Russian Federation
MD, associate professor at the Department of Hospital Therapy, Medical Faculty
E. Yu. Gubareva
Russian Federation
MD, assistant of the Department of Faculty Therapy, physician at Functional Diagnostics Department
G. M. Dabylova
Kazakhstan
assistant of the Department of Internal Diseases with the Course of Propaedeutics
A. I. Demchenko
Russian Federation
laboratory assistant at the Department of Faculty Therapy, intern doctor
O. Yu. Dolgikh
Russian Federation
MD, chief physician
M. Y. Duyshobayev
Kyrgyzstan
physician at the department of urgent cardiology and reanmation-2
D. S. Evdokimov
Russian Federation
full-time postgraduate student at the Department of Faculty Therapy 2020-2023
K. E. Egorova
Russian Federation
gastroenterologist of nephrology department
A. N. Ermilova
Russian Federation
medical advisor, laboratory assistant at thе Department of the Internal Medicine3.Resident in psychiatry 2019-2021
A. E. Zheldybayeva
Kazakhstan
assistant of the Department of Internal Diseases with the course of propaedeutics
N. V. Zarechnova
Russian Federation
deputy chief physician at Clinical Hospital №2
Yu. D. Zimina
Russian Federation
therapist
S. Yu. Ivanova
Russian Federation
deputy chief physician
E. Yu. Ivanchenko
Russian Federation
MD, associate professor at the department of therapy and cardiology
M. V. Ilina
Russian Federation
therapist
M. V. Kazakovtseva
Russian Federation
PhD, associate professor of the Department of Clinical Therapy
E. V. Kazymova
Russian Federation
deputy chief physician
Yu. S. Kalinina
Russian Federation
assistant at the Department of Нospital Therapy and Immunology with Postgraduate Education Course
N. A. Kamardina
Russian Federation
cardiologist
A. M. Karachenova
Russian Federation
therapist, pulmonologist
I. A. Karetnikov
Russian Federation
deputy chief phisician
N. A. Karoli
Russian Federation
MD, PhD, professor at the Department of Hospital Therapy, Medical Faculty
O. V. Karpov
Russian Federation
PhD, psychiatrist
M. Kh. Karsiev
Russian Federation
attending physician
D. S. Кaskaeva
Russian Federation
candidate of medical sciences, associate professor of the Department of Outpatient Therapy and Family Medicine with a Course of Postgraduate Education
K. F. Kasymova
Russian Federation
resident of Department of Нospital Therapy and Immunology with Postgraduate Education Course
Zh. B. Kerimbekova
Kyrgyzstan
junior researcher at the department of mountain medicine and pulmonary hypertension
A. Sh. Kerimova
Russian Federation
assistant of a chief physician
E. S. Kim
Russian Federation
student, administrator
N. V. Kiseleva
Russian Federation
clinical resident of the Department of Therapy and Cardiology
D. A. Klimenko
Russian Federation
laboratory assistant at the Department of Faculty Therapy, intern doctor
A. V. Klimova
Russian Federation
general practitioner, postgraduate student at the Department of the Internal Medicine
O. V. Kovalishena
Russian Federation
MD, PhD, head of the Department of Epidemiology, Microbiology and Evidence-Based Medicine, director of the Research Institute of Preventive Medicine
E. V. Kolmakova
Russian Federation
MD, associate professor at the Department of Internal Diseases, Clinical Pharmacology and Nephrology
T. P. Kolchinskaya
Russian Federation
deputy chief physician on outpatient therapy
M. I. Kolyadich
Russian Federation
PhD, associate professor of the Department of Propedeutics of Internal Medicine, deputy chief physician
O. V. Kondriakova
Russian Federation
student
M. P. Konoval
Russian Federation
therapist
D. Yu. Konstantinov
Russian Federation
PhD, associate professor, head of the Department of Infectious Diseases
E. A. Konstantinova
Russian Federation
MD, associate professor at the Department of Infectious Diseases
V. A. Kordukova
Russian Federation
resident in pulmonology
E. V. Koroleva
Russian Federation
physician of the department of cardiology №2
A. Yu. Kraposhina
Russian Federation
PhD in Medicine, associate professor at the Department of Hospital Therapy and Immunology with Postgraduate Education
T. V. Kriukova
Russian Federation
project manager
A. S. Kuznetsova
Russian Federation
PhD, associate professor of the Department of Clinical Therapy
T. Yu. Kuzmina
Russian Federation
MD, Phd , associate professor at the Depatment of Infecction Diseases and Epidemiology
K. V. Kuzmichev
Russian Federation
resident
Ch. K. Kulchoroeva
Kyrgyzstan
junior researcher
T. V. Kuprina
Russian Federation
postgraduated student
I. M. Kouranova
Russian Federation
deputy chief phhysician
L. V. Kurenkova
Russian Federation
attending physician
N. Yu. Kurchugina
Russian Federation
student
N. A. Kushubakova
Kyrgyzstan
junior researcher
V. I. Levankova
Russian Federation
deputy chief physician for therapy
M. Е. Levin
Russian Federation
deputy chief doctor
N. A. Lyubavina
Russian Federation
PhD, associated professor
N. A. Magdeyeva
Russian Federation
MD, associate professor at the Department of Hospital Therapy, Medical Faculty
K. V. Mazalov
Russian Federation
head of the Department of Cardiology
V. I. Majseenko
Belarus
assistant lecturer at the Department of Phthisiopulmonology with the course of the Faculty of Professional Development and Retraining
A. S. Makarova
Russian Federation
postgraduate student of the department of cardiology and functional diagnostics
A. M. Maripov
Kyrgyzstan
head of Department of Pulmonary Hypertension and High altitude medicine, leading researcher
A. A. Marusina
Russian Federation
therapist
E. S. Melnikov
Russian Federation
medical advisor, postgraduate student of the department of therapy, rheumatology, examination of temporary disability and quality of medical care named after E. E. Eichwald 2020-2023
N. B. Moiseenko
Russian Federation
student
F. N. Muradova
Russian Federation
postgraduate student of the Department of Therapy and Cardiology
R. G. Muradyan
Russian Federation
primary care physician
A. O. Myshak
Russian Federation
data analyst
N. M. Nikitina
Russian Federation
MD, PhD, professor at the Department of Hospital Therapy, Medical Faculty
B. B. Ogurlieva
Russian Federation
research assistant, сardiologist
A. A. Odegova
Russian Federation
PhD, assistant of the Department of Clinical Therapy
Yu. M. Omarova
Russian Federation
postgraduate student of the Department of Therapy and Cardiology
N. A. Omurzakova
Kyrgyzstan
MD, PhD, deputy director
Sh. O. Ospanova
Kazakhstan
assistant at the Department of Internal Diseases with the Course of Propaedeutics
E. V. Pahomova
Russian Federation
phthisiatrician of the Department of Pulmonary Tuberculosis for Adults
L. D. Petrov
Moldova, Republic of
director
S. S. Plastinina
Russian Federation
PhD, assistant professor at the Internal Medicine Department
V. A. Pogrebetskaya
Russian Federation
deputy chief physician
D. S. Polyakov
Russian Federation
PhD, assistant professor at the Department of Therapy and Cardiology
E. V. Ponomarenko
Russian Federation
cardiologist
L. L. Popova
Russian Federation
MD, PhD, professor at the Department of Infectious Diseases
N. A. Prokofeva
Russian Federation
head of the department of therapy №2
I. A. Pudova
Russian Federation
assistant at the Department of Faculty and Polyclinic Therapy, chief physician
N. A. Rakov
Russian Federation
attending physician
A. N. Rakhimov
Uzbekistan
junior researcher
N. A. Rozanova
Russian Federation
nurse
S. Serikbolkyzy
Kazakhstan
assistant of the Department of Internal Diseases with the Course of Propaedeutics
A. A. Simonov
Russian Federation
therapist
V. V. Skachkova
Russian Federation
attending physician
D. V. Soloveva
Russian Federation
student
I. A. Soloveva
Russian Federation
Dr.Med.Sci., professor, associate professor, pulmonologist
F. M. Sokhova
Russian Federation
psychiatrist
A. K. Subbotin
Russian Federation
cardiologist
I. M. Sukhomlinova
Russian Federation
therapist
A. G. Sushilova
Russian Federation
attending physician
D. R. Tagayeva
Uzbekistan
junior researcher
Yu. V. Titojkina
Russian Federation
resident
E. P. Tikhonova
Russian Federation
MD, professor, head of the Department of Infectious Diseases and Epidemiology with a Course of Postgraduate Education
D. S. Tokmin
Russian Federation
head of analytics
A. A. Tolmacheva
Russian Federation
postgraduate student, assistant of the department of Faculty Therapy n.a. Zalesskiy G.D., therapist
M. S. Torgunakova
Russian Federation
resident of Department of Нospital Therapy and Immunology with Postgraduate Education Course
K. V. Trenogina
Russian Federation
MD, cardiologist
N. A. Trostianetckaia
Russian Federation
PhD, cardiologist
D. A. Trofimov
Russian Federation
student, nurse (Department of Cardiology №4)
A. A. Tulichev
Russian Federation
PhD, assistant of Department of Internal Medicine Propedeutics, head of the Emergency Room
A. T. Tursunova
Kazakhstan
assistant of the Department of Internal Diseases with the Course of Propaedeutics
N. D. Ulanova
Russian Federation
resident
O. V. Fatenkov
Russian Federation
MD, PhD, assistant professor, director of Clinic, head of the Department of Faculty Therapy, chief therapist of the Ministry of Healthcare of Samara Region
O. V. Fedorishina
Russian Federation
MD, associate professor at the department of cardiology and functional diagnostics
T. S. Fil
Russian Federation
head of the department of gastroenterology
I. Yu. Fomina
Russian Federation
PhD, associate professor at the Department of Faculty and Outpatient Therapy, chief physician
I. S. Fominova
Russian Federation
resident
I. A. Frolova
Russian Federation
cardiologist
S. M. Tsvinger
Russian Federation
MD, rheumatologist, associate professor at the department of ambulatory care with courses of medical rehabilitation
V. V. Tsoma
Russian Federation
PhD, associate professor, Department of Internal Medicine, Institute of Continuing Medical Education, head of Additional Professional Education Department, chief freelance pulmonologist of the Health Committee of the Volgograd Region
M. B. Cholponbaeva
Kyrgyzstan
junior researcher
T. I. Chudinovskikh
Russian Federation
PhD, assistant of the Department of Hospital Therapy
O. A. Shevchenko
Russian Federation
general practitioner
T. V. Sheshina
Russian Federation
assistant at the department of clinical medicine
E. A. Shishkina
Russian Federation
MD, associate professor at the Hopspital Therapy and Cardiology Department
K. Yu. Shishkov
Russian Federation
student
S. Yu. Sherbakov
Russian Federation
resident in anaesthesiology and resuscitation
E. A. Yausheva
Russian Federation
resident
Sh. N. Musaelian
Armenia
clinical resident at cardiology department
Yu. N. Belenkov
Russian Federation
Аcademician of RAS, MD, PhD, head of Department of hospital therapy №1 medical faculty
G. P. Arutyunov
Professor, Head of the Department of Internal Medicine
References
1. Eurasian Association of Therapists. Analysis of Chronic Non-infectious Diseases Dynamics Aſter COVID-19 Infection in Adult Patients. ClinicalTrials.gov Identifier: NCT04492384. [Av. at: https://clinical-trials.gov/ct2/show/NCT04492384]
2. Arutyunov G.P., Tarlovskaya E.I., Arutyunov A.G., Belenkov Yu.N., Konradi A.O., Lopatin Yu.M. et al. International register “Analysis of Chronic Non-infectious Diseases Dynamics Aſter COVID-19 Infection in Adult Patients (ACTIV SARS-CoV-2)”. Kardiologiia. 2020;60(11):30–4. DOI: 10.18087/cardio.2020.11.n1398
3. Arutyunov G.P., Tarlovskaya E.I., Arutyunov A.G., Belenkov Yu.N., Konradi A.O., Lopatin Yu.M. et al. International register “Dynamics analysis of comorbidities in SARS-CoV-2 survivors” (AСTIV) and the register “Analysis of hospitalizations of comorbid patients infected during the second wave of SARS-CoV-2 outbreak” (AСTIV 2). Russian Journal of Cardiology. 2021;26(3):103–13. DOI: 10.15829/1560-4071-2021-4358
4. Arutyunov G.P., Tarlovskaya E.I., Arutyunov A.G., Belenkov Yu.N., Konradi A.O., Lopatin Yu.M. et al. International register “Dynamics analysis of comorbidities in SARS-CoV-2 survivors” (ACTIV SARS-CoV-2): analysis of 1,000 patients. Russian Journal of Cardiology. 2020;25(11):98–107. DOI: 10.15829/1560-4071-2020-4165
5. Kow CS, Hasan SS. Meta-analysis of Effect of Statins in Patients with COVID-19. The American Journal of Cardiology. 2020;134:153–5. DOI: 10.1016/j.amjcard.2020.08.004
6. Zhang X-J, Qin J-J, Cheng X, Shen L, Zhao Y-C, Yuan Y et al. In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19. Cell Metabolism. 2020;32(2):176-187.e4. DOI: 10.1016/j.cmet.2020.06.015
7. Reiner Ž, Hatamipour M, Banach M, Pirro M, Al-Rasadi K, Jamialahmadi T et al. Statins and the COVID-19 main protease: in silico evidence on direct interaction. Archives of Medical Science. 2020;16(3):490–6. DOI: 10.5114/aoms.2020.94655
8. Rodrigues‐Diez RR, Tejera‐Muñoz A, Marquez‐Exposito L, Rayego‐ Mateos S, Santos Sanchez L, Marchant V et al. Statins: Could an old friend help in the fight against COVID‐19? British Journal of Pharmacology. 2020;177(21):4873–86. DOI: 10.1111/bph.15166
9. Scicali R, Di Pino A, Piro S, Rabuazzo AM, Purrello F. May statins and PCSK9 inhibitors be protective from COVID-19 in familial hypercholesterolemia subjects? Nutrition, Metabolism and Cardiovascular Diseases. 2020;30(7):1068–9. DOI: 10.1016/j.numecd.2020.05.003
10. Barkas F, Milionis H, Anastasiou G, Liberopoulos E. Statins and PCSK9 inhibitors: What is their role in coronavirus disease 2019? Medical Hypotheses. 2021;146:110452. DOI: 10.1016/j.mehy.2020.110452
11. Gao C, Cai Y, Zhang K, Zhou L, Zhang Y, Zhang X et al. Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study. European Heart Journal. 2020;41(22):2058–66. DOI: 10.1093/eurheartj/ehaa433
12. Baral R, Tsampasian V, Debski M, Moran B, Garg P, Clark A et al. Association Between Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in Patients With COVID-19: A Systematic Review and Meta-analysis. JAMA Network Open. 2021;4(3):e213594. DOI: 10.1001/jamanetworkopen.2021.3594
13. Savarese G, Benson L, Sundström J, Lund LH. Association between renin–angiotensin–aldosterone system inhibitor use and COVID‐19 hospitalization and death: a 1.4 million patient nationwide registry analysis. European Journal of Heart Failure. 2021;23(3):476–85. DOI: 10.1002/ejhf.2060
14. Lopes RD, Macedo AVS, de Barros E Silva PGM, Moll-Bernardes RJ, dos Santos TM, Mazza L et al. Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19: A Randomized Clinical Trial. JAMA. 2021;325(3):254–64. DOI: 10.1001/jama.2020.25864
15. Cohen JB, Hanff TC, William P, Sweitzer N, Rosado-Santander NR, Medina C et al. Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial. The Lancet Respiratory Medicine. 2021;9(3):275–84. DOI: 10.1016/S2213-2600(20)30558-0
16. van Kimmenade RRJ, Belfroid E, Hoogervorst-Schilp J, Siebelink HJ, Janssen CW, Pinto Y. The effects of ACE2 expression mediating pharmacotherapy in COVID-19 patients. Netherlands Heart Journal. 2021;29(Suppl 1):20–34. DOI: 10.1007/s12471-021-01573-8
17. South AM, Tomlinson L, Edmonston D, Hiremath S, Sparks MA. Controversies of renin–angiotensin system inhibition during the COVID-19 pandemic. Nature Reviews Nephrology. 2020;16(6):305–7. DOI: 10.1038/s41581-020-0279-4
18. Bauer AZ, Gore R, Sama SR, Rosiello R, Garber L, Sundaresan D et al. Hypertension, medications, and risk of severe COVID‐19: A Massachusetts community‐based observational study. The Journal of Clinical Hypertension. 2021;23(1):21–7. DOI: 10.1111/jch.14101
19. Kow CS, Hasan SS. Use of antiplatelet drugs and the risk of mortality in patients with COVID-19: a meta‐analysis. Journal of Thrombosis and Thrombolysis. 2021;1–6. [Epub ahead of print]. DOI: 10.1007/s11239-021-02436-0
20. Talasaz AH, Sadeghipour P, Kakavand H, Aghakouchakzadeh M, Kordzadeh-Kermani E, Van Tassell BW et al. Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19: JACC State-of-the-Art Review. Journal of the American College of Cardiology. 2021;77(15):1903–21. DOI: 10.1016/j.jacc.2021.02.035
21. Harrison RF, Forte K, Buscher MG, Chess A, Patel A, Moylan T et al. The Association of Preinfection Daily Oral Anticoagulation Use and All-Cause in Hospital Mortality From Novel Coronavirus 2019 at 21 Days: A Retrospective Cohort Study. Critical Care Explorations. 2021;3(1):e0324. DOI: 10.1097/CCE.0000000000000324
22. Fröhlich GM, Jeschke E, Eichler U, Thiele H, Alhariri L, Reinthaler M et al. Impact of oral anticoagulation on clinical outcomes of COVID-19: a nationwide cohort study of hospitalized patients in Germany. Clinical Research in Cardiology. 2021;1–10. [Epub ahead of print]. DOI: 10.1007/s00392-020-01783-x
23. Flam B, Wintzell V, Ludvigsson JF, Mårtensson J, Pasternak B. Direct oral anticoagulant use and risk of severe COVID‐19. Journal of Internal Medicine. 2021;289(3):411–9. DOI: 10.1111/joim.13205
24. Cariou B, Hadjadj S, Wargny M, Pichelin M, Al-Salameh A, Allix I et al. Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study. Diabetologia. 2020;63(8):1500–15. DOI: 10.1007/s00125-020-05180-x
25. Khunti K, Knighton P, Zaccardi F, Bakhai C, Barron E, Holman N et al. Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England. The Lancet Diabetes & Endocrinology. 2021;9(5):293–303. DOI: 10.1016/S2213-8587(21)00050-4
26. Scheen AJ. Metformin and COVID-19: From cellular mechanisms to reduced mortality. Diabetes & Metabolism. 2020;46(6):423–6. DOI: 10.1016/j.diabet.2020.07.006
27. Dalan R, Ang LW, Tan WYT, Fong S-W, Tay WC, Chan Y-H et al. The association of hypertension and diabetes pharmacotherapy with COVID-19 severity and immune signatures: an observational study. European Heart Journal - Cardiovascular Pharmacotherapy. 2021;7(3):e48–51. DOI: 10.1093/ehjcvp/pvaa098
28. Chen Y, Yang D, Cheng B, Chen J, Peng A, Yang C et al. Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication. Diabetes Care. 2020;43(7):1399–407. DOI: 10.2337/dc20-0660
29. Rhee SY, Lee J, Nam H, Kyoung D-S, Shin DW, Kim DJ. Effects
30. of a DPP-4 Inhibitor and RAS Blockade on Clinical Outcomes of Patients with Diabetes and COVID-19. Diabetes & Metabolism Journal. 2021;45(2):251–9. DOI: 10.4093/dmj.2020.0206
31. Solerte SB, D’Addio F, Trevisan R, Lovati E, Rossi A, Pastore I et al. Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study. Diabetes Care. 2020;43(12):2999–3006. DOI: 10.2337/dc20-1521
32. Kim MK, Jeon J-H, Kim S-W, Moon JS, Cho NH, Han E et al. The Clinical Characteristics and Outcomes of Patients with Moderate-to-Severe Coronavirus Disease 2019 Infection and Diabetes in Daegu, South Korea. Diabetes & Metabolism Journal. 2020;44(4):602. DOI: 10.4093/dmj.2020.0146
33. Izzi-Engbeaya C, Distaso W, Amin A, Yang W, Idowu O, Kenkre JS et al. Adverse outcomes in COVID-19 and diabetes: a retrospective cohort study from three London teaching hospitals. BMJ Open Diabetes Research & Care. 2021;9(1):e001858. DOI: 10.1136/bmjdrc-2020-001858
34. Wargny M, Potier L, Gourdy P, Pichelin M, Amadou C, Benhamou P-Y et al. Predictors of hospital discharge and mortality in patients with diabetes and COVID-19: updated results from the nationwide CORONADO study. Diabetologia. 2021;64(4):778–94. DOI: 10.1007/s00125-020-05351-w
35. Kew KM, Seniukovich A. Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews. 2014;3:CD010115. DOI: 10.1002/14651858.CD010115.pub2
36. Matsuyama S, Kawase M, Nao N, Shirato K, Ujike M, Kamitani W et al. The inhaled corticosteroid ciclesonide blocks coronavirus RNA replication by targeting viral NSP15. DOI: 10.1101/2020.03.11.987016. Av. at: http://biorxiv.org/lookup/doi/10.1101/2020.03.11.987016.2020.
37. Yamaya M, Nishimura H, Deng X, Sugawara M, Watanabe O, Nomura K et al. Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells. Respiratory Investigation. 2020;58(3):155–68. DOI: 10.1016/j.resinv.2019.12.005
Review
For citations:
Tarlovskaya E.I., Arutyunov A.G., Konradi A.O., Lopatin Yu.M., Rebrov A.P., Tereshchenko S.N., Chesnikova A.I., Hayrapetyan H.G., Babin A.P., Bakulin I.G., Bakulina N.V., Balykova L.A., Blagonravova A.S., Boldina M.V., Vaisberg A.R., Galyavich A.S., Gomonova V.V., Grigorieva N.Yu., Gubareva I.V., Demko I.V., Evzerikhina A.V., Zharkov A.V., Kamilova U.K., Kim Z.F., Kuznetsova T.Yu., Lareva N.V., Makarova E.V., Malchikova S.V., Nedogoda S.V., Petrova M.M., Pochinka I.G., Protasov K.V., Protsenko D.N., Ruzanau D.Yu., Sayganov S.A., Sarybaev A.S., Selezneva N.M., Sugraliev A.B., Fomin I.V., Khlynova O.V., Chizhova O.Yu., Shaposhnik I.I., Shсukarev D.A., Abdrahmanova A.K., Avetisian S.A., Avoyan H.G., Azarian K.K., Aimakhanova G.T., Ayipova D.A., Akunov A.Ch., Alieva M.K., Aparkina A.V., Aruslanova O.R., Ashina E.Yu., Badina O.Yu., Barisheva O.Yu., Batchayeva A.S., Bitieva A.M., Bikhteyev I.U., Borodulina N.A., Bragin M.V., Budu A.M., Burygina L.A., Bykova G.A., Vagapova K.R., Varlamova D.D., Vezikova N.N., Verbitskaya E.A., Vilkova O.E., Vinnikova E.A., Vustina V.V., Gаlova E.A., Genkel V.V., Gorshenina E.I., Gostishev R.V., Grigorieva E.V., Gubareva E.Yu., Dabylova G.M., Demchenko A.I., Dolgikh O.Yu., Duyshobayev M.Y., Evdokimov D.S., Egorova K.E., Ermilova A.N., Zheldybayeva A.E., Zarechnova N.V., Zimina Yu.D., Ivanova S.Yu., Ivanchenko E.Yu., Ilina M.V., Kazakovtseva M.V., Kazymova E.V., Kalinina Yu.S., Kamardina N.A., Karachenova A.M., Karetnikov I.A., Karoli N.A., Karpov O.V., Karsiev M.Kh., Кaskaeva D.S., Kasymova K.F., Kerimbekova Zh.B., Kerimova A.Sh., Kim E.S., Kiseleva N.V., Klimenko D.A., Klimova A.V., Kovalishena O.V., Kolmakova E.V., Kolchinskaya T.P., Kolyadich M.I., Kondriakova O.V., Konoval M.P., Konstantinov D.Yu., Konstantinova E.A., Kordukova V.A., Koroleva E.V., Kraposhina A.Yu., Kriukova T.V., Kuznetsova A.S., Kuzmina T.Yu., Kuzmichev K.V., Kulchoroeva Ch.K., Kuprina T.V., Kouranova I.M., Kurenkova L.V., Kurchugina N.Yu., Kushubakova N.A., Levankova V.I., Levin M.Е., Lyubavina N.A., Magdeyeva N.A., Mazalov K.V., Majseenko V.I., Makarova A.S., Maripov A.M., Marusina A.A., Melnikov E.S., Moiseenko N.B., Muradova F.N., Muradyan R.G., Myshak A.O., Nikitina N.M., Ogurlieva B.B., Odegova A.A., Omarova Yu.M., Omurzakova N.A., Ospanova Sh.O., Pahomova E.V., Petrov L.D., Plastinina S.S., Pogrebetskaya V.A., Polyakov D.S., Ponomarenko E.V., Popova L.L., Prokofeva N.A., Pudova I.A., Rakov N.A., Rakhimov A.N., Rozanova N.A., Serikbolkyzy S., Simonov A.A., Skachkova V.V., Soloveva D.V., Soloveva I.A., Sokhova F.M., Subbotin A.K., Sukhomlinova I.M., Sushilova A.G., Tagayeva D.R., Titojkina Yu.V., Tikhonova E.P., Tokmin D.S., Tolmacheva A.A., Torgunakova M.S., Trenogina K.V., Trostianetckaia N.A., Trofimov D.A., Tulichev A.A., Tursunova A.T., Ulanova N.D., Fatenkov O.V., Fedorishina O.V., Fil T.S., Fomina I.Yu., Fominova I.S., Frolova I.A., Tsvinger S.M., Tsoma V.V., Cholponbaeva M.B., Chudinovskikh T.I., Shevchenko O.A., Sheshina T.V., Shishkina E.A., Shishkov K.Yu., Sherbakov S.Yu., Yausheva E.A., Musaelian Sh.N., Belenkov Yu.N., Arutyunov G.P. Analysis of influence of background therapy for comorbidities in the period before infection on the risk of the lethal COVID outcome. Data from the international ACTIV SARS-CoV-2 registry («Analysis of chronic non-infectious diseases dynamics after COVID-19 infection in adult patients SARS-CoV-2»). Kardiologiia. 2021;61(9):20-32. (In Russ.) https://doi.org/10.18087/cardio.2021.9.n1680